Natroba Now Approved for Younger Children with Head Lice
ParaPRO announced that the Food and Drug Administration (FDA) has approved an expanded age range for Natroba (spinosad) Topical Suspension, to include children ≥6 months of age who have pediculosis capitis (head lice).
Natroba, a pediculicide derived from soil microbe, was initially approved in 2011 for use in patients ≥4 years of age. The active ingredient causes neuronal excitation in insects. After periods of hyperexcitation, lice become paralyzed and die.
Natroba Topical Suspension is available as a 0.9% strength in 4oz bottles.
For more information call (855) 628-4622 or visit Natroba.com.